scanX
Home
Lactose

Lactose

150.00
-0.25
(-0.17%)
Market Cap (₹ Cr.)
₹189
52 Week High
200.00
Book Value
₹
52 Week Low
56.53
PE Ratio
23.33
PB Ratio
4.02
PE for Sector
42.33
PB for Sector
23.57
ROE
2.98 %
ROCE
19.78 %
Dividend Yield
0.00 %
EPS
₹6.44
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
72.91 %
Net Income Growth
461.77 %
Cash Flow Change
11.28 %
ROE
383.79 %
ROCE
96.99 %
EBITDA Margin (Avg.)
-3.81 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
7
9
10
9
9
8
8
12
9
8
5
9
10
11
11
10
9
10
10
10
10
6
8
10
10
9
11
12
15
10
13
17
26
28
25
33
30
30
Expenses
5
6
5
6
6
6
6
8
5
6
6
6
8
9
8
7
7
7
8
8
8
6
7
8
7
7
8
9
9
7
11
14
22
24
21
27
23
24
EBITDA
2
3
4
2
2
2
2
4
4
2
-1
3
3
3
2
3
3
2
3
2
2
0
1
2
3
2
3
3
6
3
3
3
4
4
4
6
6
6
Operating Profit %
25 %
28 %
44 %
27 %
14 %
21 %
28 %
29 %
42 %
22 %
-19 %
29 %
22 %
22 %
22 %
24 %
26 %
24 %
26 %
20 %
19 %
5 %
13 %
20 %
27 %
17 %
24 %
22 %
38 %
24 %
18 %
16 %
15 %
14 %
14 %
18 %
21 %
19 %
Depreciation
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
Interest
1
1
1
1
1
1
1
1
1
1
1
2
1
1
1
1
1
1
2
1
1
1
1
2
1
1
1
1
1
1
1
2
2
2
1
1
1
1
Profit Before Tax
-0
1
3
1
0
0
0
2
2
0
-3
0
0
0
0
0
0
0
0
0
-0
-2
-1
-1
0
-1
0
0
3
0
0
0
1
1
1
4
4
3
Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0
-0
0
0
-0
0
0
0
0
1
0
-0
0
0
0
0
1
1
1
Net Profit
-0
0
2
1
-0
-0
0
1
1
-0
-2
0
-0
1
0
0
0
0
0
0
-0
-1
-1
-0
0
-1
0
0
3
0
0
0
1
1
1
3
2
2
EPS in ₹
-0.12
0.46
2.17
0.84
-0.14
-0.20
0.40
1.26
1.21
-0.02
-1.76
0.42
-0.01
0.66
0.20
0.16
0.24
0.12
0.03
0.03
-0.12
-1.34
-0.87
-0.49
0.26
-0.57
0.28
0.19
2.24
0.07
0.07
0.11
0.71
0.76
0.64
2.09
1.91
1.80
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
80
83
85
83
82
84
88
90
101
101
Fixed Assets
62
61
64
63
60
62
59
59
56
55
Current Assets
13
17
17
17
18
20
20
23
37
36
Capital Work in Progress
1
1
1
0
1
0
4
0
0
0
Investments
0
0
0
0
0
0
1
1
0
0
Other Assets
16
21
20
19
20
22
25
30
45
46
Total Liabilities
64
63
58
51
47
50
53
51
61
54
Current Liabilities
20
26
27
13
12
11
12
15
26
25
Non Current Liabilities
44
37
31
38
35
38
42
36
34
28
Total Equity
16
20
27
32
34
34
35
39
41
47
Reserve & Surplus
7
12
17
22
24
24
24
27
28
35
Share Capital
8
9
10
10
10
10
11
13
13
13
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
-0
-0
3
-2
1
1
-0
-1
1
Investing Activities
-23
3
-5
-2
-2
-3
-6
-1
-1
-2
Operating Activities
13
1
8
0
5
7
2
8
8
9
Financing Activities
10
-5
-3
4
-5
-4
5
-8
-8
-6
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
49.13 %
49.13 %
49.13 %
52.50 %
53.79 %
53.79 %
53.79 %
53.79 %
53.79 %
53.79 %
53.77 %
53.66 %
53.65 %
53.65 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.68 %
0.68 %
0.68 %
0.64 %
0.62 %
0.62 %
0.62 %
0.62 %
0.62 %
0.62 %
0.62 %
0.62 %
0.62 %
0.62 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
50.19 %
50.19 %
50.19 %
46.87 %
45.59 %
45.59 %
45.59 %
45.59 %
45.59 %
45.59 %
45.61 %
45.72 %
45.74 %
45.74 %

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,898.40 4,48,867.59 42.57 49,887.17 12.06 9,648 42.62 73.07
Divis Laboratories
5,379.30 1,43,130.05 85.50 8,184.00 0.89 1,600 20.79 62.72
Cipla
1,621.80 1,32,699.41 29.85 26,520.66 14.17 4,155 17.77 48.91
Dr Reddys Laboratories
6,744.40 1,11,701.59 20.07 28,905.40 12.36 5,578 -0.90 52.63
Mankind Pharma
2,685.15 1,08,123.84 55.10 10,615.63 19.57 1,942 9.89 69.14
Zydus Life Science
1,068.00 1,06,987.83 25.66 19,831.50 13.82 3,831 30.78 36.40
Lupin
2,188.15 1,01,202.24 44.71 20,141.50 19.94 1,936 77.69 51.87
Aurobindo Pharma
1,515.30 89,528.49 24.96 29,559.25 17.55 3,169 61.17 49.98
Alkem Laboratories
6,197.15 74,427.42 34.62 12,978.42 9.84 1,811 91.18 57.49
Glenmark Pharmaceuticals
1,678.30 47,658.76 - 12,653.09 6.58 -1,831 96.52 52.73

Corporate Action

Technical Indicators

RSI(14)
Neutral
36.76
ATR(14)
Less Volatile
7.05
STOCH(9,6)
Neutral
33.96
STOCH RSI(14)
Neutral
27.14
MACD(12,26)
Bearish
-0.22
ADX(14)
Weak Trend
19.52
UO(9)
Bearish
49.12
ROC(12)
Downtrend And Accelerating
-6.07
WillR(14)
Neutral
-66.84
Bearish
5
Neutral
4
Bullish
0
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Candlestick Screeners
Technical Screeners
Price & Volume Screeners
Fundamental Screeners
Intraday Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.